| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972398 | The Journal of Heart and Lung Transplantation | 2008 | 6 Pages |
Abstract
Frequent EBV load monitoring identifies patients at high risk for PTLD development. Azathioprine and ATG are major risk factors for increased EBV load and PTLD and patients may benefit from a change of immunosuppression in addition to pre-emptive anti-viral or anti-tumor strategies.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Stephan MD, Christiane Renner, Markus MD, Hashim MD, PhD, Hans Brendan MD, Felix MD, PhD, Roland MD, PhD, Petra MD, PhD,